Clinical Trials Browser

Phase 2 × Carcinoma, Hepatocellular × Lenalidomide × Clear all

NCT01545804 2017-02-09

Lenalidomide as Second-line Treatment for Advanced Hepatocellular Carcinoma

Phase 2 Completed

Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms